San Diego, CA -- (SBWIRE) -- 04/07/2015 -- An investor in shares of Hologic, Inc. (NASDAQ:HOLX) filed a lawsuit against Carl C. Icahn and others to recover short swing insider trading profits.

Investors who purchased shares of Hologic, Inc. (NASDAQ:HOLX) and currently hold any of those NASDAQ:HOLX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff claims that the defendants are required to disgorge any profits they earn through short-swing insider trading when they are statutory insiders.

In late November 2013 activist investor Carl Icahn disclosed a 12.5% stake in Hologic, Inc..

Subsequently, Hologic, Inc. adopted a poison pill to prevent a hostile takeover.

Hologic, Inc. reported that its Total Revenue rose from over $2.49 billion for the 12 months period that ended on Sept. 28, 2013 to over $2.53 billion for the 12 months period that ended on Sept. 27, 2014 and that its Net Loss of over $1.17 billion for the 12 months period that ended on Sept. 28, 2013 turned into a Net Income of $17.30 million for the 12 months period that ended on Sept. 27, 2014.

Shares of Hologic, Inc. (NASDAQ:HOLX) grew from $19.08 per share in November 2012 to as high as $33.34 per share on March 31, 2015.

On April 2, 2015, NASDAQ: HOLX shares closed at $32.94 per share.

Those who purchased shares of Hologic, Inc. (NASDAQ:HOLX), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com